Saturday 17 October 2026
Export OGN’s income statement to Excel — free account
Organon & Co.
OGN Healthcare Drug Manufacturers General
Organon & Co.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, down 2.92% from fiscal 2024. In the quarter to June 2026, revenue fell 2.26%, EPS fell 26.8%, free cash flow fell 83.0% and total debt fell 3.86%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
13.76
0.00
0.00%
Follow OGN
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | 4 | 5 | 4 | 5 | 5 |
P/E ratio |
4.54 | 4.54 | 4.54 | 4.54 | 5.71 | 7.80 | 3.66 | 4.45 | 9.96 |
Altman Z-Score |
— | — | — | — | 1.52 | 1.51 | 1.26 | 1.27 | 1.09 |
P/S ratio |
1.35 | 1.35 | 1.35 | 1.35 | 1.22 | 1.16 | 0.60 | 0.60 | 0.30 |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | 1.41 | 1.64 | 1.68 | 1.81 | 1.78 |
P/FCF ratio |
3.39 | 3.39 | 3.39 | 3.39 | 3.91 | 13.09 | 8.29 | 5.78 | 4.48 |
Beneish M-Score |
— | — | — | (2.93) | (3.56) | (2.40) | (2.21) | (2.62) | (2.68) |
P/Operating CF |
6.48 | 6.48 | 6.48 | 6.48 | 164.26 | 26.71 | 9.46 | 9.83 | 13.20 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | 45 |
P/B ratio |
1.79 | 1.79 | 1.79 | 1.79 | 0.00 | 0.00 | 0.00 | 8.13 | 2.47 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.49 | 1.49 | 1.49 | 1.49 | 2.56 | 2.48 | 1.89 | 1.88 | 1.60 |
EV/EBITDA |
3.75 | 3.75 | 3.75 | 3.75 | 8.38 | 8.61 | 7.92 | 7.24 | 6.92 |
EV/Operating CF |
3.40 | 3.40 | 3.40 | 3.40 | 7.46 | 17.88 | 14.80 | 12.82 | 14.19 |
EV/FCF |
3.76 | 3.76 | 3.76 | 3.76 | 8.16 | 28.15 | 26.10 | 18.16 | 23.93 |
Quick Ratio |
— | 1.20 | 1.34 | 0.39 | 0.82 | 0.87 | 0.84 | 0.75 | 0.80 |
Current Ratio |
— | 2.40 | 2.95 | 1.33 | 1.45 | 1.56 | 1.54 | 1.60 | 1.82 |
Net Debt/EBITDA |
0.00 | (0.02) | (0.05) | 0.01 | 4.69 | 4.61 | 5.40 | 4.94 | 5.62 |
Debt/Assets |
0.00% | 0.00% | 1.12% | 0.31% | 85.52% | 81.36% | 72.65% | 67.78% | 67.18% |
Debt/Equity |
— | 0.00 | 0.02 | 0.01 | (6.06) | (9.99) | (125.14) | 18.81 | 11.49 |
Asset Turnover |
0.00 | 0.00 | 1.47 | 0.63 | 0.61 | 0.57 | 0.54 | 0.51 | 0.48 |
Operating CF/Net income |
1.90 | 1.71 | 0.94 | 1.06 | 1.60 | 0.94 | 0.78 | 1.09 | 3.74 |
Capex/Depreciation |
0.00 | (0.04) | (0.26) | (1.76) | (1.93) | (1.48) | (1.07) | (0.96) | (0.47) |
Interest Coverage |
261.76 | 129.95 | 194.53 | 174.75 | 6.94 | 3.72 | 2.39 | 2.64 | 1.63 |
| 0.00% | 32.18% | 48.09% | 34.50% | 67.92% | (76.42%) | (212.68%) | 429.85% | 30.56% | |
| 0.00% | 0.00% | 61.02% | 20.91% | 13.00% | 8.48% | 8.89% | 6.87% | 1.44% | |
ROIC |
— | 0.00% | 33.80% | 31.74% | 16.25% | 13.41% | 9.82% | 9.90% | 5.84% |
Return on Tangible Assets |
0.00% | 76.35% | 97.69% | 115.02% | 63.25% | 37.63% | 36.89% | 30.88% | 5.73% |
Average Days of Receivables |
0.00 | 59.92 | 69.18 | 58.00 | 80.02 | 87.20 | 101.64 | 77.41 | 78.16 |
Research and Development Expense of Revenue |
3.38% | 3.73% | 2.83% | 3.21% | 5.38% | 7.63% | 8.43% | 7.32% | 5.89% |
Selling, General and Administrative Expense of Revenue |
21.76% | 20.59% | 18.55% | 20.76% | 26.46% | 27.60% | 30.23% | 27.49% | 27.69% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.49 | 0.51 | 0.49 | 0.48 | 0.43 | 0.47 | 0.41 |
Share Based Compensation of Revenue |
0.00% | 0.57% | 0.53% | 0.61% | 0.94% | 1.21% | 1.61% | 1.64% | 1.24% |
Graham Net Nets |
(0.23) | (0.23) | (0.23) | (0.23) | (1.09) | (1.11) | (2.03) | (2.16) | (4.17) |
Graham Number |
0.00 | 0.00 | 0.00 | 64.41 | 0.00 | 0.00 | 0.00 | 11.76 | 6.85 |
Earnings Yield |
22.04% | 22.04% | 22.04% | 22.04% | 17.50% | 12.83% | 27.33% | 22.45% | 10.04% |
Free Cash Flow Yield |
29.46% | 29.46% | 29.46% | 29.46% | 25.58% | 7.64% | 12.07% | 17.29% | 22.30% |
Revenue per Share |
41.50 | 38.64 | 30.68 | 25.77 | 24.86 | 24.30 | 24.54 | 24.91 | 23.95 |
Operating CF per Share |
13.51 | 14.57 | 11.91 | 9.01 | 8.52 | 3.38 | 3.13 | 3.65 | 2.70 |
Capex per Share |
0.00 | (0.27) | (0.35) | (0.99) | (1.49) | (1.23) | (0.99) | (1.07) | (1.10) |
Free Cash Flow per Share |
13.51 | 14.30 | 11.57 | 8.02 | 7.03 | 2.15 | 2.14 | 2.58 | 1.60 |
Cash per Share |
0.00 | 0.96 | 1.26 | 0.05 | 2.91 | 2.78 | 2.72 | 2.63 | 2.21 |
Shareholders Equity per Share |
0.00 | 0.00 | 27.75 | 21.64 | (5.95) | (3.51) | (0.27) | 1.84 | 2.90 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.00 | 27.75 | 21.64 | (5.95) | (3.51) | (0.27) | 1.84 | 2.90 |
Free Cash Flow |
3,419.00 | 3,618.00 | 2,932.00 | 2,034.00 | 1,783.00 | 545.00 | 547.00 | 663.00 | 415.00 |
Working Capital |
— | 2,169.00 | 2,614.00 | 894.00 | 1,163.00 | 1,419.00 | 1,590.00 | 1,630.00 | 1,962.00 |
Capital Expenditures |
(86.00) | (69.00) | (88.00) | (250.00) | (377.00) | (313.00) | (252.00) | (276.00) | (285.00) |
Net Current Asset Value |
— | 3,714.00 | 442.00 | (1,056.00) | (8,429.00) | (7,916.00) | (7,620.00) | (8,281.00) | (7,763.00) |
EV/EBIT |
4.01 | 4.01 | 4.01 | 4.01 | 9.00 | 9.77 | 9.40 | 8.76 | 12.05 |
Capex to Sales |
0.00 | 0.01 | 0.01 | 0.04 | 0.06 | 0.05 | 0.04 | 0.04 | 0.05 |
Price to Operating Income |
3.63 | 3.63 | 3.63 | 3.63 | 4.31 | 4.54 | 2.99 | 2.79 | 2.26 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.00 | 2.57 | 0.49 | 0.14 | 0.20 | 0.21 | 0.20 | 0.25 | 0.47 |
Cash ROIC |
0.00% | 920.61% | 39.24% | 36.79% | 21.32% | 6.24% | 5.83% | 6.61% | 4.16% |
Accounts Receivable Turnover |
0.00 | 6.35 | 5.05 | 5.20 | 5.21 | 4.32 | 3.89 | 4.13 | 4.62 |
Accounts Payable Turnover |
0.00 | 17.16 | 8.31 | 8.20 | 2.90 | 1.83 | 2.06 | 2.18 | 2.76 |
Inventory Turnover |
0.00 | 4.55 | 2.20 | 2.14 | 2.61 | 2.39 | 2.17 | 2.04 | 2.13 |
Average Days of Payables |
0.00 | 22.48 | 41.41 | 44.61 | 211.77 | 180.11 | 190.70 | 156.56 | 119.70 |
Days of Inventory on Hand |
0.00 | 77.31 | 171.91 | 157.27 | 140.21 | 159.59 | 190.84 | 179.38 | 176.78 |
Average Receivables |
— | 1,539.50 | 1,539.50 | 1,256.00 | 1,210.00 | 1,428.50 | 1,609.50 | 1,551.00 | 1,344.50 |
Average Payables |
— | 273.50 | 273.50 | 258.50 | 820.50 | 1,257.00 | 1,223.00 | 1,233.50 | 1,052.50 |
Average Inventory |
— | 1,032.50 | 1,032.50 | 992.00 | 914.00 | 959.00 | 1,159.00 | 1,318.00 | 1,363.50 |
Average Assets |
— | 0.00 | 5,274.00 | 10,328.50 | 10,395.00 | 10,818.00 | 11,506.50 | 12,579.50 | 12,984.00 |
Average Common Equity |
— | 6,691.50 | 6,691.50 | 6,260.50 | 1,989.00 | (1,200.00) | (481.00) | 201.00 | 612.00 |
Columns are period end dates